 | | | | (Reuters Health) - For late-term pregnancies, inducing labor at 41 weeks may be safer than waiting until week 42, a large Swedish study suggests. | | |
| | | (Reuters Health) - It's a common and persistent myth that static stretching improves running performance and decreases the risk of injuries, researchers say. | | |
| | | (Reuters Health) - Older adults with normal weight but a wider waist may be at a higher risk of developing dementia, a Korean study suggests. | | |
| | | Swiss drugmaker Novartis's new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of treatments, including Kymriah for cancer and Zolgensma for spinal muscular atrophy, in 2020. | | |
| | | Militia fighters in eastern Congo killed four people and injured several others in attacks on two Ebola response centers on Thursday, in what the United Nations described as a setback to efforts to contain the disease. | | |
| | | British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals. | | |
| | | Chinese health authorities on Thursday reported a fresh case of bubonic plague in the country's northern Inner Mongolia region, bringing the total number of plague cases to four since the beginning of the month. | | |
| | | Massachusetts on Wednesday adopted the country's toughest ban on the sale of flavored tobacco and vaping products, including menthol cigarettes, in response to a rise in youth vaping and an outbreak of vaping-related serious lung injuries. | | |
| | | (Reuters Health) - Breast cancer can be difficult to detect in women with extremely dense breast tissue, but a new Dutch study indicates that getting an MRI scan can spot tumors that would otherwise be missed. | | |
| | | (Reuters Health) - A small study finds that some people lose their ability to swim when their Parkinson's disease is treated with deep brain stimulation. | | |
| | | (Reuters Health) - Many supplements marketed for brain health may contain piracetam, an ingredient not proven effective for preventing or easing dementia or cognitive impairment and not approved for sale in the U.S., researchers say. | | |
|
| |
